UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 315

Sortiert nach

Size-Dependent Immunogenicity: Therapeutic and Protective Properties of Nano-Vaccines against Tumors

The Journal of immunology (1950), 2004-09, Vol.173 (5), p.3148-3154

2004

Volltextzugriff (PDF)

Up to 15-year clinical follow-up of a pilot Phase III immunotherapy study in stage II breast cancer patients using oxidized mannan-MUC1

Immunotherapy, 2013-11, Vol.5 (11), p.1177-1182

2013

Volltextzugriff (PDF)

Mannan-mediated gene delivery for cancer immunotherapy

Immunology, 2007-03, Vol.120 (3), p.325-335

2007

Volltextzugriff (PDF)

Mannan-MUC1–Pulsed Dendritic Cell Immunotherapy: A Phase I Trial in Patients with Adenocarcinoma

Clinical cancer research, 2006-02, Vol.12 (3), p.869-877

2006

Volltextzugriff (PDF)

A Glycopeptide in Complex with MHC Class I Uses the GalNAc Residue as an Anchor

Proceedings of the National Academy of Sciences - PNAS, 2003-12, Vol.100 (25), p.15029-15034

2003

Volltextzugriff (PDF)

Cellular Mucins: Targets for Immunotherapy

Critical reviews in immunology, 2017, Vol.37 (2-6), p.421

2017

Volltextzugriff (PDF)

Dendritic cell immunotherapy: clinical outcomes

Clinical & translational immunology, 2014-07, Vol.3 (7), p.e21-n/a

2014

Volltextzugriff (PDF)

Tribute to Carl-Gustav Groth (1933-2014), first president of the International Xenotransplantation Association

Xenotransplantation (Københaven), 2014-03, Vol.21 (2), p.97-98

2014

Volltextzugriff (PDF)

Delivery of tumor associated antigens to antigen presenting cells using penetratin induces potent immune responses

Vaccine, 2006-04, Vol.24 (16), p.3191-3202

2006

Volltextzugriff (PDF)

Pim-1 Kinase Stability Is Regulated by Heat Shock Proteins and the Ubiquitin-Proteasome Pathway

Molecular cancer research, 2005-03, Vol.3 (3), p.170-181

2005

Volltextzugriff (PDF)

Carbohydrate residues downstream of the terminal Galα(1,3)Gal epitope modulate the specificity of xenoreactive antibodies

Immunology and cell biology, 2007-11, Vol.85 (8), p.623-632

2007

Volltextzugriff (PDF)

Cripto: A novel target for antibody-based cancer immunotherapy

Cancer research (Chicago, Ill.), 2004-06, Vol.64 (11), p.4018-4023

2004

Volltextzugriff (PDF)

Mucins: Structure, function, and associations with malignancy

BioEssays, 1992-09, Vol.14 (9), p.619-625

1992

Volltextzugriff (PDF)

CD46 protects pig islets from antibody but not cell-mediated destruction in the mouse

Xenotransplantation (Københaven), 2003-11, Vol.10 (6), p.615-621

2003

Volltextzugriff (PDF)

Honorary Membership of International Xenotransplantation Association Conferred Upon Professor Ian F C McKenzie (September 18, 2007)

Xenotransplantation (Københaven), 2008-09, Vol.15 (5), p.285-289

McKenzie, Ian F C

2008

Volltextzugriff (PDF)

Combined transgenic expression of α-galactosidase and α1,2-fucosyltransferase leads to optimal reduction in the major xenoepitope Galα(1,3)Gal

Proceedings of the National Academy of Sciences - PNAS, 1997-12, Vol.94 (26), p.14677-14682

1997

Volltextzugriff (PDF)

Reply to ‘Response to Milland et al.: Carbohydrate residues downstream of the terminal galα(1,3)gal epitope modulate the specificity of xenoreactive antibodies’

Immunology and cell biology, 2008-11, Vol.86 (8), p.633-634

2008

Volltextzugriff (PDF)

Anti-MUC1 Antibodies React Directly with MUC1 Peptides Presented by Class I H2 and HLA Molecules

The Journal of immunology (1950), 1998-07, Vol.161 (2), p.767-775

1998

Volltextzugriff (PDF)

Expression of MUC2‐mucin in colorectal adenomas and carcinomas of different histological types

International journal of cancer, 1994-11, Vol.59 (3), p.301-306

1994

Volltextzugriff (PDF)

Tissue‐specific and allelic expression of the complement regulator CD46 is controlled by alternative splicing

European journal of immunology, 1992-06, Vol.22 (6), p.1513-1518

1992

Volltextzugriff (PDF)

Fucosyl transferase (H) transgenic heart transplants to Gal-/- mice

Transplantation, 2000-10, Vol.70 (8), p.1205

2000

Volltextzugriff (PDF)

7th Congress of the International Xenotransplantation Association

Xenotransplantation (Københaven), 2004-05, Vol.11 (3), p.230-232

McKenzie, Ian F. C.

2004

Volltextzugriff (PDF)

Immunohistochemical study of mucin carbohydrates and core proteins in hepatolithiasis and cholangiocarcinoma

International journal of cancer, 1993-08, Vol.55 (1), p.82-91

1993

Volltextzugriff (PDF)

Tissue expression, structure and function of the murine Ly-6 family of molecules

Immunology and cell biology, 1995-08, Vol.73 (4), p.277-296

1995

Volltextzugriff (PDF)

Parameters for using mannan-MUC1 fusion protein to induce cellular immunity

Cancer Immunology, Immunotherapy, 1998, Vol.45 (6), p.321-326

1998

Volltextzugriff (PDF)

1 – 25 von 315

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(308)
Mit Volltextzugriff
(247)

Publikationsform

Sprache

Englisch
(315)
Japanisch
(26)

Erscheinungsjahr

n.n

Thema

Science & Technology
(209)
Animals
(196)
Life Sciences & Biomedicine
(195)
Mice
(163)
Immunology
(139)
Humans
(125)
Biological And Medical Sciences
(113)
Fundamental And Applied Biological Sciences. Psychology
(67)
Molecular Sequence Data
(52)
Amino Acid Sequence
(51)
Medical Sciences
(48)
Fundamental Immunology
(47)
Female
(44)
Genetics & Heredity
(42)
Mice, Inbred Balb C
(42)
T-Lymphocytes - Immunology
(37)
Antibodies, Monoclonal - Immunology
(36)
Mice, Inbred C57bl
(35)
Oncology
(35)
Immunotherapy
(32)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Size-Dependent Immunogenicity: Therapeutic and Protective Properties of Nano-Vaccines against Tumors

Up to 15-year clinical follow-up of a pilot Phase III immunotherapy study in stage II breast cancer patients using oxidized mannan-MUC1

Mannan-mediated gene delivery for cancer immunotherapy

Mannan-MUC1–Pulsed Dendritic Cell Immunotherapy: A Phase I Trial in Patients with Adenocarcinoma

A Glycopeptide in Complex with MHC Class I Uses the GalNAc Residue as an Anchor

Cellular Mucins: Targets for Immunotherapy

Dendritic cell immunotherapy: clinical outcomes

Tribute to Carl-Gustav Groth (1933-2014), first president of the International Xenotransplantation Association

Delivery of tumor associated antigens to antigen presenting cells using penetratin induces potent immune responses

Pim-1 Kinase Stability Is Regulated by Heat Shock Proteins and the Ubiquitin-Proteasome Pathway

Carbohydrate residues downstream of the terminal Galα(1,3)Gal epitope modulate the specificity of xenoreactive antibodies

Cripto: A novel target for antibody-based cancer immunotherapy

Mucins: Structure, function, and associations with malignancy

CD46 protects pig islets from antibody but not cell-mediated destruction in the mouse

Honorary Membership of International Xenotransplantation Association Conferred Upon Professor Ian F C McKenzie (September 18, 2007)

Combined transgenic expression of α-galactosidase and α1,2-fucosyltransferase leads to optimal reduction in the major xenoepitope Galα(1,3)Gal

Reply to ‘Response to Milland et al.: Carbohydrate residues downstream of the terminal galα(1,3)gal epitope modulate the specificity of xenoreactive antibodies’

Anti-MUC1 Antibodies React Directly with MUC1 Peptides Presented by Class I H2 and HLA Molecules

Expression of MUC2‐mucin in colorectal adenomas and carcinomas of different histological types

Tissue‐specific and allelic expression of the complement regulator CD46 is controlled by alternative splicing

Fucosyl transferase (H) transgenic heart transplants to Gal-/- mice

7th Congress of the International Xenotransplantation Association

Immunohistochemical study of mucin carbohydrates and core proteins in hepatolithiasis and cholangiocarcinoma

Tissue expression, structure and function of the murine Ly-6 family of molecules

Parameters for using mannan-MUC1 fusion protein to induce cellular immunity

Suchergebnisse filtern